Trial intelligence / Profile preview

Sciatic perineural levobupivacaine ± clonidine infusion to prevent phantom limb pain and cardiac morbidity after lower limb amputation

2006-005667-26Phase 4Terminated

Sponsor
Ninewells Hospital
Start
Apr 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in phantom limb pain (PLP), postoperative pain and arrhythmogenic cardiomyopathy (ACM) comparing Saline infusion (placebo), Levobupivacaine infusion and Levobupivacaine + clonidine infusion (3 arms). Primary endpoints: Incidence of phantom limb pain at 12 months and Cardiac outcomes after lower limb amputation. Started Apr 2007; status: terminated.

02

Drugs

levobupivacaineclonidine
03

Conditions

phantom limb pain (PLP)postoperative painarrhythmogenic cardiomyopathy (ACM)

Beyond the preview

Go deeper on 2006-005667-26.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-005667-26.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call